Maximizing patient safety with newly approved therapies: Focus on SGLT2 inhibitors

Research output: Contribution to journal › Comment/debate

Access to Document

@article{c55c06d36342486bbd8404f07be3ae8d,

title = "Maximizing patient safety with newly approved therapies: Focus on SGLT2 inhibitors",

author = "McGill, {Janet B.}",

year = "2015",

month = sep,

doi = "10.4158/EP15849.CO",

language = "English",

volume = "21",

pages = "1076--1078",

journal = "Endocrine Practice",

issn = "1530-891X",

number = "9",

}

TY - JOUR

T1 - Maximizing patient safety with newly approved therapies

T2 - Focus on SGLT2 inhibitors

AU - McGill, Janet B.

PY - 2015/9

Y1 - 2015/9

UR - http://www.scopus.com/inward/record.url?scp=84982161966&partnerID=8YFLogxK

U2 - 10.4158/EP15849.CO

DO - 10.4158/EP15849.CO

M3 - Comment/debate

C2 - 26214109

AN - SCOPUS:84982161966

SN - 1530-891X

VL - 21

SP - 1076

EP - 1078

JO - Endocrine Practice

JF - Endocrine Practice

IS - 9

ER -